| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A picture of health. Paintings and drawings of breast cancer care by Susan Macfarlane
|
Samuel, L.
|
|
1996
|
5 |
3 |
p. 230-
1 p.
|
article
|
| 2 |
A review of the management of the male breast carcinoma based on an analysis of 420 treated cases
|
Ribeiro, G.G.
|
|
1996
|
5 |
3 |
p. 141-146
6 p.
|
article
|
| 3 |
Athymic nude mouse model for the study of new antioestrogens in breast cancer
|
Osborne, C.K.
|
|
1996
|
5 |
3 |
p. 181-185
5 p.
|
article
|
| 4 |
Bibliography of the breast
|
|
|
1996
|
5 |
3 |
p. B9-B12
nvt p.
|
article
|
| 5 |
14. Biological and molecular markers are bad prognostic but good predictive factors
|
Gusterson, B.A.
|
|
1996
|
5 |
3 |
p. 163-164
2 p.
|
article
|
| 6 |
Biological background to aromatase inhibition
|
Dowsett, M.
|
|
1996
|
5 |
3 |
p. 196-201
6 p.
|
article
|
| 7 |
13. Biological predictors of response to hormone and chemotherapy
|
Silvestrini, R.
|
|
1996
|
5 |
3 |
p. 163-
1 p.
|
article
|
| 8 |
6. Biologic variables could predict specific relapse types in node-negative breast cancer
|
Daidone, M.Grazia
|
|
1996
|
5 |
3 |
p. 158-
1 p.
|
article
|
| 9 |
25. Breast complaints and age as indicators of breast disease
|
Lumachi, F.
|
|
1996
|
5 |
3 |
p. 166-167
2 p.
|
article
|
| 10 |
Clinical studies with the specific ‘pure’ antioestrogen ICI 182780
|
Howell, A.
|
|
1996
|
5 |
3 |
p. 192-195
4 p.
|
article
|
| 11 |
24. Clinical usefulness of biological markers in breast cancer
|
Querzoli, P.
|
|
1996
|
5 |
3 |
p. 166-
1 p.
|
article
|
| 12 |
11. Computational aids for adjuvant therapy decision making for patients with primary breast cancer
|
Ravdin, P.M.
|
|
1996
|
5 |
3 |
p. 161-162
2 p.
|
article
|
| 13 |
3. Decision making in clinical practice
|
Clark, G.M.
|
|
1996
|
5 |
3 |
p. 155-
1 p.
|
article
|
| 14 |
19. Determination of p185/neu in peritumoral area versus malignant human breast tissue: a comparison study
|
Malagutti, R.
|
|
1996
|
5 |
3 |
p. 165-
1 p.
|
article
|
| 15 |
Diary of events
|
|
|
1996
|
5 |
3 |
p. 231-
1 p.
|
article
|
| 16 |
20. Evaluation of oestrogen and progesterone receptors in breast cancer by comparing computer-assisted image analysis of immunocytochemical assay with enzyme immunoassay
|
Cavaliere, A.
|
|
1996
|
5 |
3 |
p. 165-
1 p.
|
article
|
| 17 |
21. Expression of apoptosis-suppressing protein BCL-2 in breast carcinomas is associated with the presence of oestrogen receptors and tumour diploidy
|
Santeusanio, G.
|
|
1996
|
5 |
3 |
p. 165-166
2 p.
|
article
|
| 18 |
18. Expression of plasminogen activator inhibitor type 2 in invasive breast cancer
|
Fersis, N.
|
|
1996
|
5 |
3 |
p. 165-
1 p.
|
article
|
| 19 |
5. Histopathological indicators of prognosis and their limitations
|
Zafrani, B.
|
|
1996
|
5 |
3 |
p. 157-158
2 p.
|
article
|
| 20 |
15. IL 1 alpha, IL 1 beta, IL 2, IL 6 and soluble IL 2 receptor in the serum and in the culture supernatants and lymphocyte membrane-bound P55 chain in breast and gynaecologic cancers
|
Mantovani, G.
|
|
1996
|
5 |
3 |
p. 164-
1 p.
|
article
|
| 21 |
Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: correlation with morphological features and recently proposed schemes for histological classification
|
Millis, R.R.
|
|
1996
|
5 |
3 |
p. 113-122
10 p.
|
article
|
| 22 |
17. Immunohistochemical evaluation of metallothionein overexpression in invasive breast carcinoma and relationship with pathological and biological prognostic factors
|
Betta, P.G.
|
|
1996
|
5 |
3 |
p. 164-165
2 p.
|
article
|
| 23 |
27. In breast cancer deletions on the short arm of chromosome 17 (17p13.3-ter) are associated with a worse prognosis
|
Liscia, D.S.
|
|
1996
|
5 |
3 |
p. 167-
1 p.
|
article
|
| 24 |
In vitro and animal studies with antiprogestins
|
Michna, H.
|
|
1996
|
5 |
3 |
p. 224-228
5 p.
|
article
|
| 25 |
Male breast cancer: the importance of recognizing family history and the preliminary results of linkage analysis to BRCA1 and BRCA2
|
Schofield, A.
|
|
1996
|
5 |
3 |
p. 147-151
5 p.
|
article
|
| 26 |
Models of new antioestrogen action in vivo: primary tumours
|
Anderson, E.
|
|
1996
|
5 |
3 |
p. 186-191
6 p.
|
article
|
| 27 |
Mucocoele-like lesions detected by the mammographic presence of suspicious clustered microcalcifications
|
Davies, J.D.
|
|
1996
|
5 |
3 |
p. 135-140
6 p.
|
article
|
| 28 |
New endocrine treatments for breast cancer: biological and clinical aspects
|
Howell, A.
|
|
1996
|
5 |
3 |
p. 170-174
5 p.
|
article
|
| 29 |
Pharmacology of new aromatase inhibitors
|
Lønning, P.E.
|
|
1996
|
5 |
3 |
p. 202-208
7 p.
|
article
|
| 30 |
16. Positive correlation between Doppler colour analysis and immunocytochemical staining to evaluate vessel number in breast cancer
|
Dautry, R.M.
|
|
1996
|
5 |
3 |
p. 164-
1 p.
|
article
|
| 31 |
8. Prognosis based on primary breast carcinoma instead of pathological nodal status
|
Ménard, S.
|
|
1996
|
5 |
3 |
p. 159-
1 p.
|
article
|
| 32 |
1. Prognostic and predictive factors for early breast cancer
|
Baum, M.
|
|
1996
|
5 |
3 |
p. 154-
1 p.
|
article
|
| 33 |
2. Prognostic factors for the classification and staging of breast cancers
|
Badellino, F.
|
|
1996
|
5 |
3 |
p. 155-
1 p.
|
article
|
| 34 |
Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer
|
Collett, K.
|
|
1996
|
5 |
3 |
p. 123-126
4 p.
|
article
|
| 35 |
26. Prognostic value of c-erbB2 gene amplification detected in archival human breast carcinomas by quantitative differential PCR
|
Schniirch, H.G.
|
|
1996
|
5 |
3 |
p. 167-
1 p.
|
article
|
| 36 |
Properties and mode of action of pure antioestrogens in breast cancer in vitro
|
Nicholson, R.I.
|
|
1996
|
5 |
3 |
p. 175-180
6 p.
|
article
|
| 37 |
9. Quality assurance in the diagnosis of breast cancer
|
Holland, R.
|
|
1996
|
5 |
3 |
p. 159-160
2 p.
|
article
|
| 38 |
10. Quality assurance of tissue and serum markers
|
Gion, M.
|
|
1996
|
5 |
3 |
p. 160-161
2 p.
|
article
|
| 39 |
Results of phase II and phase III trials with new aromatase inhibitors
|
Jonat, W.
|
|
1996
|
5 |
3 |
p. 209-215
7 p.
|
article
|
| 40 |
22. Significance of McMPLA-ase in breast cancer
|
Serra, F.G.
|
|
1996
|
5 |
3 |
p. 166-
1 p.
|
article
|
| 41 |
23. Structure and expression of the RON tyrosine kinase receptor gene in human breast cancer
|
Marchib, S.
|
|
1996
|
5 |
3 |
p. 166-
1 p.
|
article
|
| 42 |
Tamoxifen compliance in a clinical trial
|
Dewar, J.A.
|
|
1996
|
5 |
3 |
p. 152-153
2 p.
|
article
|
| 43 |
Tamoxifen: the need for a monitoring protocol
|
Ciatto, S.
|
|
1996
|
5 |
3 |
p. 229-
1 p.
|
article
|
| 44 |
4. The design and clinical use of the nottingham prognostic index in breast cancer
|
Blamey, R.W.
|
|
1996
|
5 |
3 |
p. 156-157
2 p.
|
article
|
| 45 |
Value of immunohistochemical-determined oestrogen receptor status and proliferative activity in breast cancer: a retrospective study including patients treated by endocrine therapy at the time of recurrence
|
Jensen, V.
|
|
1996
|
5 |
3 |
p. 127-134
8 p.
|
article
|
| 46 |
12. What is a predictive factor?
|
Goldhirsch, A.
|
|
1996
|
5 |
3 |
p. 162-163
2 p.
|
article
|
| 47 |
7. What is available and relevant from the biologist?
|
Gullick, W.J.
|
|
1996
|
5 |
3 |
p. 158-159
2 p.
|
article
|
| 48 |
Why are there two progesterone receptors?
|
Horwitz, K.B.
|
|
1996
|
5 |
3 |
p. 216-223
8 p.
|
article
|
Journal description